Analgesics (Pharmacies) - Central & Western Europe

  • Central & Western Europe
  • Revenue in the Analgesics market is projected to reach US$3.14bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.74%, resulting in a market volume of US$4.15bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$9.36 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Central & Western Europe is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences play a crucial role in the growth of the Analgesics market in Central & Western Europe. Consumers in this region are increasingly seeking convenient and accessible healthcare solutions. Pharmacies provide a convenient one-stop-shop for individuals to purchase analgesic products, making them a preferred choice for many customers. Additionally, there is a growing demand for over-the-counter pain relief medication, as individuals are becoming more proactive in managing their health and seeking immediate relief from minor ailments. Trends in the market further support the growth of the Analgesics market in Central & Western Europe. One notable trend is the increasing availability of a wide range of analgesic products in pharmacies. Pharmacies are expanding their product offerings to cater to the diverse needs of customers, including different types of pain relief medication, topical creams, and natural remedies. This trend is driven by the desire to provide comprehensive healthcare solutions and meet the evolving demands of consumers. Another trend in the market is the growing emphasis on natural and holistic remedies. Many individuals in Central & Western Europe are becoming more conscious of the potential side effects of traditional analgesic medications and are seeking alternative options. As a result, pharmacies are stocking a variety of natural and herbal analgesic products to cater to this demand. This trend aligns with the overall shift towards holistic healthcare and wellness in the region. Local special circumstances also contribute to the development of the Analgesics market in Central & Western Europe. The well-established healthcare infrastructure and high accessibility of pharmacies in this region make it easier for individuals to access analgesic products. Additionally, the presence of strong regulatory frameworks ensures that the quality and safety of analgesic medications are closely monitored, instilling trust and confidence in consumers. Underlying macroeconomic factors further support the growth of the Analgesics market in Central & Western Europe. The region's stable and growing economy provides individuals with the purchasing power to invest in healthcare products, including analgesics. Moreover, the aging population in many countries within Central & Western Europe contributes to the increasing demand for pain relief medication. As the population ages, the prevalence of chronic pain and age-related ailments rises, driving the need for effective analgesics. In conclusion, the Analgesics (Pharmacies) market in Central & Western Europe is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility offered by pharmacies, along with the availability of a wide range of analgesic products, cater to the evolving needs of consumers. The emphasis on natural remedies and the well-established healthcare infrastructure further contribute to the market's positive trajectory.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)